People's Insurance Company (Group) of China Toekomstige groei
Future criteriumcontroles 0/6
De winst van People's Insurance Company (Group) of China zal naar verwachting dalen met 2.5% per jaar, terwijl de jaarlijkse omzet naar verwachting zal groeien met 7.4% per jaar. De winst per aandeel zal naar verwachting dalen met 3.2% per jaar. Het rendement op het eigen vermogen zal over 3 jaar naar verwachting 11.3% zijn.
Belangrijke informatie
-2.5%
Groei van de winst
-3.2%
Groei van de winst per aandeel
| Insurance winstgroei | -2.1% |
| Inkomstengroei | 7.4% |
| Toekomstig rendement op eigen vermogen | 11.3% |
| Dekking van analisten | Good |
| Laatst bijgewerkt | 06 Nov 2024 |
Recente toekomstige groei-updates
Recent updates
A Piece Of The Puzzle Missing From The People's Insurance Company (Group) of China Limited's (HKG:1339) 25% Share Price Climb
Sep 26
The People's Insurance Company (Group) of China Limited (HKG:1339) Doing What It Can To Lift Shares
Jun 11Here's Why People's Insurance Company (Group) of China (HKG:1339) Has Caught The Eye Of Investors
Nov 01Here's Why We Think People's Insurance Company (Group) of China (HKG:1339) Is Well Worth Watching
Jul 17Does People's Insurance Company (Group) of China (HKG:1339) Deserve A Spot On Your Watchlist?
Apr 18Do People's Insurance Company (Group) of China's (HKG:1339) Earnings Warrant Your Attention?
Jan 18Here's Why I Think People's Insurance Company (Group) of China (HKG:1339) Is An Interesting Stock
Apr 08Should You Be Adding People's Insurance Company (Group) of China (HKG:1339) To Your Watchlist Today?
Jan 07Here's Why I Think People's Insurance Company (Group) of China (HKG:1339) Might Deserve Your Attention Today
Sep 08What Is The Ownership Structure Like For The People's Insurance Company (Group) of China Limited (HKG:1339)?
Feb 07
A Look At People's Insurance Company (Group) of China's (HKG:1339) Share Price Returns
Jan 03Winst- en omzetgroeiprognoses
| Datum | Inkomsten | Inkomsten | Vrije kasstroom | Geldmiddelen uit operationele activiteiten | Gem. Aantal analisten |
|---|---|---|---|---|---|
| 12/31/2026 | 632,689 | 35,277 | N/A | 115,661 | 7 |
| 12/31/2025 | 592,669 | 33,388 | N/A | 103,415 | 9 |
| 12/31/2024 | 560,564 | 38,715 | N/A | 84,298 | 9 |
| 9/30/2024 | 565,305 | 38,150 | 84,106 | 87,771 | N/A |
| 6/30/2024 | 538,228 | 25,128 | 77,170 | 80,672 | N/A |
| 3/31/2024 | 526,158 | 19,564 | 59,012 | 62,490 | N/A |
| 12/31/2023 | 525,327 | 22,322 | 66,976 | 70,549 | N/A |
| 9/30/2023 | 513,174 | 21,623 | 76,784 | 82,731 | N/A |
| 6/30/2023 | 509,850 | 26,348 | 75,231 | 81,598 | N/A |
| 3/31/2023 | 509,143 | 27,646 | 81,134 | 87,612 | N/A |
| 12/31/2022 | 492,823 | 25,382 | 64,545 | 71,121 | N/A |
| 9/30/2022 | 536,742 | 24,963 | 74,383 | 77,974 | N/A |
| 6/30/2022 | 525,724 | 23,536 | 69,109 | 73,820 | N/A |
| 3/31/2022 | 560,136 | 22,506 | 69,093 | 73,276 | N/A |
| 12/31/2021 | 594,548 | 21,476 | 69,076 | 72,731 | N/A |
| 9/30/2021 | 603,529 | 22,075 | 57,014 | 62,216 | N/A |
| 6/30/2021 | 586,978 | 24,285 | 52,197 | 60,591 | N/A |
| 3/31/2021 | 584,559 | 22,161 | 36,224 | 46,229 | N/A |
| 12/31/2020 | 582,139 | 20,036 | 20,251 | 31,867 | N/A |
| 9/30/2020 | 584,167 | 19,503 | 26,180 | 37,026 | N/A |
| 6/30/2020 | 570,809 | 19,263 | 39,189 | 45,193 | N/A |
| 3/31/2020 | 560,850 | 20,699 | 35,372 | 41,001 | N/A |
| 12/31/2019 | 550,890 | 22,135 | 31,554 | 36,808 | N/A |
| 9/30/2019 | 490,629 | 22,802 | 15,866 | 20,367 | N/A |
| 6/30/2019 | 515,675 | 18,345 | 13,012 | 19,242 | N/A |
| 3/31/2019 | 506,492 | 15,629 | -4,453 | 1,220 | N/A |
| 12/31/2018 | 497,308 | 12,912 | -21,919 | -16,803 | N/A |
| 9/30/2018 | 494,141 | 15,121 | -23,717 | -19,355 | N/A |
| 6/30/2018 | 490,973 | 17,329 | N/A | -21,908 | N/A |
| 3/31/2018 | 486,919 | 16,714 | N/A | -11,266 | N/A |
| 12/31/2017 | 482,865 | 16,099 | N/A | -625 | N/A |
| 9/30/2017 | 468,253 | 15,717 | N/A | -903 | N/A |
| 6/30/2017 | 453,641 | 15,335 | N/A | -1,182 | N/A |
| 3/31/2017 | 448,207 | 14,790 | N/A | 11,325 | N/A |
| 12/31/2016 | 442,773 | 14,245 | N/A | 23,831 | N/A |
| 9/30/2016 | 436,231 | 14,346 | N/A | 27,088 | N/A |
| 6/30/2016 | 429,689 | 14,446 | N/A | 30,345 | N/A |
| 3/31/2016 | 417,976 | 16,994 | N/A | 25,393 | N/A |
| 12/31/2015 | 406,262 | 19,542 | N/A | 20,441 | N/A |
| 9/30/2015 | 397,728 | 19,429 | N/A | 5,684 | N/A |
| 6/30/2015 | 389,194 | 19,316 | N/A | -9,074 | N/A |
| 3/31/2015 | 370,231 | 16,213 | N/A | -4,736 | N/A |
| 12/31/2014 | 351,267 | 13,109 | N/A | -399 | N/A |
| 9/30/2014 | 348,091 | 10,151 | N/A | 21,003 | N/A |
| 6/30/2014 | 344,915 | 7,193 | N/A | 42,405 | N/A |
| 3/31/2014 | 324,588 | 7,657 | N/A | 48,128 | N/A |
| 12/31/2013 | 304,260 | 8,121 | N/A | 53,851 | N/A |
Toekomstige groeivoorspellingen analisten
Verdiensten versus spaarpercentage: De winst van 1339 zal naar verwachting de komende 3 jaar dalen ( -2.5% per jaar).
Winst versus markt: De winst van 1339 zal naar verwachting de komende 3 jaar dalen ( -2.5% per jaar).
Hoge groeiwinsten: De winst van 1339 zal naar verwachting de komende 3 jaar dalen.
Omzet versus markt: De omzet van 1339 ( 7.4% per jaar) zal naar verwachting langzamer groeien dan de markt Hong Kong ( 7.8% per jaar).
Hoge groei-inkomsten: De omzet van 1339 ( 7.4% per jaar) zal naar verwachting langzamer groeien dan 20% per jaar.
Groeiprognoses winst per aandeel
Toekomstig rendement op eigen vermogen
Toekomstige ROE: Het rendement op eigen vermogen 1339 zal naar verwachting over 3 jaar laag zijn ( 11.3 %).